# HADLIMA

NDC: 50090-6705
Generic name: adalimumab-bwwd
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230701

FDA application: BLA761059

## Active ingredients

- ADALIMUMAB: 40 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-6705"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-6705
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7345f276-102e-4175-b7ef-ff1706b05472